2007 Annual Meeting | Primer of Cognitive Neurology
02:15 PM - 03:00 PM |
Structural and Genetic Underpinnings of Cortical Asymmetry and Handedness
Daniel H. Geschwind, MD, PhD |
|
03:00 PM - 03:45 PM |
Left Versus Right Anterior Temporal Lobe Functions Related to Words, Famous People, and Faces
Maria Luisa Gorno Tempini, MD, PhD |
|
03:45 PM - 04:00 PM |
Break
|
|
04:00 PM - 04:45 PM |
Left Frontal Insular Functions in Speech Versus Right Frontal Insular Roles in Emotion
Howard J. Rosen, MD |
|
04:45 PM - 05:30 PM |
Right Hemisphere Control of Spatial Cognition
Andrew E. Budson, MD |
|
05:30 PM - 06:00 PM |
Case Discussions
|
Daniel H. Geschwind, MD, PhD | Dr. Geschwind has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Ovid Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AcuraStem, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axial Biotherapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Falcon Computing. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier-Biological Psychiatry. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NYAS. Dr. Geschwind has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Covington& Burling LLP. Dr. Geschwind has stock in none related to talk. The institution of Dr. Geschwind has received research support from CurePSP. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from Rainwater Charitable Foundation. The institution of Dr. Geschwind has received research support from NIMH. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from NIH. The institution of Dr. Geschwind has received research support from The Simons Foundation. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from NIMH. The institution of Dr. Geschwind has received research support from NINDS/NIA. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from NIH/NINDS. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from U of Virginia and NIH/NIMH. The institution of Dr. Geschwind has received research support from NIH. The institution of Dr. Geschwind has received research support from NIH/NHGRI. The institution of Dr. Geschwind has received research support from NIH/NIMH. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. |
Howard J. Rosen, MD | Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Alector that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities. |
Maria Luisa Gorno Tempini, MD, PhD | The institution of Dr. Gorno Tempini has received research support from the NIH. |
Andrew E. Budson, MD | Dr. Budson has received personal compensation for serving as an employee of Boston Center for Memory. Dr. Budson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Budson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Budson has received research support from Department of Veterans Affairs. The institution of Dr. Budson has received research support from NIH. The institution of Dr. Budson has received research support from Bristol Myers Squibb. The institution of Dr. Budson has received research support from VoxNeuro. Dr. Budson has received publishing royalties from a publication relating to health care. Dr. Budson has received publishing royalties from a publication relating to health care. Dr. Budson has a non-compensated relationship as a Alzheimer's Advisory Panel with Commonwealth of Massachusetts that is relevant to AAN interests or activities. |
Bruce L. Miller, MD, FAAN | Dr. Miller has nothing to disclose. |